Company Filing History:
Years Active: 2010
Title: Innovator in Pharmaceuticals: Jun Yong Ha
Introduction: Jun Yong Ha is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the pharmaceutical industry, particularly in the field of pain management and related diseases. His innovative approach has led to the development of a novel class of compounds that serve as vanilloid receptor antagonists.
Latest Patents: Jun Yong Ha holds a patent for "Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same." This invention relates to the development of new compounds that act on the vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) and provides a pharmaceutical composition for preventing or treating a wide range of conditions, including pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorders, urinary bladder hypersensitivity, and inflammatory diseases, among others.
Career Highlights: Jun Yong Ha currently works at Amorepacific Corporation, where his research focuses on enhancing the efficacy of treatments in the field of pain management and other health conditions. His innovative spirit has enabled him to contribute substantially to the research and development sector of the company.
Collaborations: Throughout his career, Jun Yong Ha has collaborated with notable colleagues, including Sun-Young Kim and Jin Kwan Kim. These partnerships have fostered a collaborative environment that promotes the exchange of ideas and drives forward the potential of pharmaceutical innovations.
Conclusion: Jun Yong Ha stands out as an inventor whose work in developing novel therapeutic compounds is paving the way for new treatments in the healthcare sector. His dedication to research in pharmacology and active collaborations with fellow scientists demonstrate his contribution to advancing medical science, significantly impacting patients suffering from various ailments.